Preeclampsia to cardiovascular disease: life course analysis of biomarkers and risk

Ended Project Grant Awarded Last action

Award ID
R01HL139844
Recipient
Awarding agency
Obligated
$13,511,522

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date
Originally
Funding
  • $11,233,264.99 Federal
  • $2,278,257.00 Non-federal
Place of performance
California, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $2,278,257 $0
Amendment $2,278,257 $2,278,257
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $2,192,149 $0
Amendment $0 $0
Amendment $2,217,157 $0
Amendment $0 $0
Original award $2,267,445 $0
Show all 15

Subawards

Subrecipient Amount Awarded
Statens Serum Institut The overall aim of this project is to identify biomarkers associated with - and possibly predictive of cardiovascular disease in women with a history of… $102,108

Quick answers

Who received award R01HL139844?

R01HL139844 was awarded to The Leland Stanford Junior University by National Heart Lung and Blood Institute (National Institutes of Health) on September 1, 2018.

How much is award R01HL139844 worth?

$13,511,522 has been obligated on R01HL139844: $11,233,265 in federal funding and $2,278,257 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award